Design strategies of hybrid metallic nanoparticles for theragnostic applications

Nanotechnology

Volumn 24, Issue 43, 2013, Pages

  Gautier, J ^a   Allard Vannier, E ^a   Herve Aubert K ^a   Souce M ^a   Chourpa, I ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-CANCER AGENTS; DIAGNOSTIC FUNCTIONS; FUNCTIONALIZATIONS; GOLD NANOPARTICLES; METALLIC NANOPARTICLES; ORGANIC MATERIALS; SURFACE FUNCTIONALIZATION; TARGETING LIGANDS;

HYBRID MATERIALS; NANOPARTICLES; NANOSYSTEMS; SURFACE CHEMISTRY;

LOADING;

ANTINEOPLASTIC AGENT; COLLOID; DOXORUBICIN; DRUG CARRIER; FERRIC ION; FERRIC OXIDE; LIPOSOME; METAL NANOPARTICLE; POLYMER;

CHEMICAL PHENOMENA; CHEMISTRY; COLLOID; STATIC ELECTRICITY; SURFACE PROPERTY; SYNTHESIS; REVIEW;

ANTINEOPLASTIC AGENTS; COLLOIDS; DOXORUBICIN; DRUG CARRIERS; FERRIC COMPOUNDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; METAL NANOPARTICLES; POLYMERS; STATIC ELECTRICITY; SURFACE PROPERTIES;

EID: 84885783774     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/24/43/432002     Document Type: Review

References (104)

1. Huang H-C, Barua S, Sharma G, Dey S K and Rege K 2011 Inorganic nanoparticles for cancer imaging and therapy J. Control. Release 155 344-57
2. Klostergaard J and Seeney C E 2012 Magnetic nanovectors for drug delivery Maturitas 73 33-44
3. Owens D E III and Peppas N A 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 93-102 (Pubitemid 41773257)
4. Van der Zee J 2002 Heating the patient: a promising approach? Ann. Oncol. 13 1173-84 (Pubitemid 34960124)
5. Xie J, Lee S and Chen X 2010 Nanoparticle-based theranostic agents Adv. Drug Deliv. Rev. 62 1064-79
6. Mirza A Z and Shamshad H 2011 Preparation and characterization of doxorubicin functionalized gold nanoparticles Eur. J. Med. Chem. 46 1857-60
7. Nguyen D T, Kim D-J and Kim K-S 2011 Controlled synthesis and biomolecular probe application of gold nanoparticles Micron 42 207-27
8. Zong S, Wang Z, Yang J, Wang C, Xu S and Cui Y 2012 A SERS and fluorescence dual mode cancer cell targeting probe based on silica coated Au@Ag core-shell nanorods Talanta 97 368-75
9. Wang Z, Zong S, Yang J, Song C, Li J and Cui Y 2010 One-step functionalized gold nanorods as intracellular probe with improved SERS performance and reduced cytotoxicity Biosens. Bioelectron. 26 241-7
10. Rana S, Bajaj A, Mout R and Rotello V M 2012 Monolayer coated gold nanoparticles for delivery applications Adv. Drug Deliv. Rev. 64 200-16
11. Mahmoudi M, Sant S, Wang B, Laurent S and Sen T 2011 Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy Adv. Drug Deliv. Rev. 63 24-46
12. Gupta A K and Gupta M 2005 Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 3995-4021 (Pubitemid 40044762)
13. Petcharoen K and Sirivat A 2012 Synthesis and characterization of magnetite nanoparticles via the chemical co-precipitation method Mater. Sci. Eng. B 177 421-7
14. Veiseh O, Gunn J W and Zhang M 2010 Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv. Drug Deliv. Rev. 62 284-304
15. Duncan B, Kim C and Rotello V M 2010 Gold nanoparticle platforms as drug and biomacromolecule delivery systems J. Control. Release 148 122-7
16. Frens G 1973 Controlled nucleation for regulation of particle size in monodisperse gold suspensions Nature Phys. Sci. 241 20-2
17. Vigderman L and Zubarev E R 2012 Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules Adv. Drug Deliv. Rev. 65 663-76
18. Massart R 1981 Preparation of aqueous magnetic liquids in alkaline and acidic media IEEE Trans. Magn. 17 1247-8 (Pubitemid 11497282)
19. Chourpa I, Douziech-Eyrolles L, Ngaboni-Okassa L, Fouquenet J-F, Cohen-Jonathan S, Soucé M, Marchais H and Dubois P 2005 Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy Analyst 130 1395-403 (Pubitemid 41508853)
20. Zhang D, Tong Z, Li S, Zhang X and Ying A 2008 Fabrication and characterization of hollow Fe3O4 nanospheres in a microemulsion Mater. Lett. 62 4053-5
21. Fang C, Bhattarai N, Sun C and Zhang M 2009 Functionalized nanoparticles with long-term stability in biological media Small 5 1637-41
22. Yang X et al 2011 cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging Biomaterials 32 4151-60
23. Huber D 2005 Synthesis, properties, and applications of iron nanoparticles Small 1 482-501 (Pubitemid 43951747)
24. Pinna N, Garnweitner G, Antonietti M and Niederberger M 2005 A general nonaqueous route to binary metal oxide nanocrystals involving a C-C bond cleavage J. Am. Chem. Soc. 127 5608-12 (Pubitemid 40569872)
25. Lee S-Y and Harris M T 2006 Surface modification of magnetic nanoparticles capped by oleic acids: characterization and colloidal stability in polar solvents J. Colloid Interface Sci. 293 401-8 (Pubitemid 41628177)
26. Huber D L, Venturini E L, Martin J E, Provencio P P and Patel R J 2004 Synthesis of highly magnetic iron nanoparticles suitable for field structuring using a β-diketone surfactant J. Magn. Magn. Mater. 278 311-6
27. Huang X and El-Sayed M A 2010 Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy J. Adv. Res. 1 13-28
28. Park J-H, von Maltzahn G, Ong L L, Centrone A, Hatton T A, Ruoslahti E, Bhatia S N and Sailor M J 2010 Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery Adv. Mater. 22 880-5
29. De Dios A S and Díaz-García M E 2010 Multifunctional nanoparticles: analytical prospects Anal. Chim. Acta 666 1-22
30. You J, Zhang G and Li C 2012 Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release ACS Nano 4 1033-41
31. Thanh N T K and Green L A W 2010 Functionalisation of nanoparticles for biomedical applications Nano Today 5 213-30
32. Dias A M G C, Hussain A, Marcos A S and Roque A C A 2011 A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides Biotechnol. Adv. 29 142-55
33. Neuberger T, Schöpf B, Hofmann H, Hofmann M and von Rechenberg B 2005 Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system J. Magn. Magn. Mater. 293 483-96 (Pubitemid 40608969)
34. Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P and Chourpa I 2008 Novel method of doxorubicin - SPION reversible association for magnetic drug targeting Int. J. Pharm. 363 170-6
35. Allard-Vannier E, Cohen-Jonathan S, Gautier J, Hervé-Aubert K, Munnier E, Soucé M, Legras P, Passirani C and Chourpa I 2012 Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo Eur. J. Pharm. Biopharm. 81 498-505
36. Wang M and Thanou M 2010 Targeting nanoparticles to cancer Pharmacol. Res. 62 90-9
37. Cao N, Cheng D, Zou S, Ai H, Gao J and Shuai X 2011 The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells Biomaterials 32 2222-32
38. Gautier J, Munnier E, Paillard A, Hervé K, Douziech-Eyrolles L, Soucé M, Dubois P and Chourpa I 2012 A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting Int. J. Pharm. 423 16-25
39. Kaaki K, Hervé-Aubert K, Chiper M, Shkilnyy A, Soucé M, Benoit R, Paillard A, Dubois P, Saboungi M-L and Chourpa I 2012 Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting Langmuir 28 1496-505
40. Lee H, Yu M K, Park S, Moon S, Min J J, Jeong Y Y, Kang H-W and Jon S 2012 Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo J. Am. Chem. Soc. 129 12739-45 (Pubitemid 350004485)
41. Barenholz Y (Chezy) 2012 Doxil® - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 117-34
42. Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T and Müller R 2000 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B 18 301-13 (Pubitemid 30479870)
43. Hervé K et al 2008 The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications Nanotechnology 19 465608
44. Gu Y-J, Cheng J, Man C W-Y, Wong W-T and Cheng S H 2012 Gold-doxorubicin nanoconjugates for overcoming multidrug resistance Nanomedicine 8 204-11
45. Prabaharan M, Grailer J J, Pilla S, Steeber D A and Gong S 2009 Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery Biomaterials 30 6065-75
46. Fang C, Kievit F M, Veiseh O, Stephen Z R, Wang T, Lee D, Ellenbogen R G and Zhang M 2012 Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach J. Control. Release 162 233-41
47. Schwartzberg A M, Olson T Y, Talley C E and Zhang J Z 2006 Synthesis, characterization, and tunable optical properties of hollow gold nanospheres J. Phys. Chem. B 110 19935-44 (Pubitemid 44626355)
48. Kievit F M, Wang F Y, Fang C, Mok H, Wang K, Silber J R, Ellenbogen R G and Zhang M 2011 Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro J. Control. Release 152 76-83
49. Gu Y-J, Cheng J, Lin C-C, Lam Y W, Cheng S H and Wong W-T 2009 Nuclear penetration of surface functionalized gold nanoparticles Toxicol. Appl. Pharmacol. 237 196-204
50. Maeng J H et al 2010 Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer Biomaterials 31 4995-5006
51. Agrawal S K, Sanabria-DeLong N, Coburn J M, Tew G N and Bhatia S R 2006 Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers J. Control. Release 112 64-71
52. Sahu S K, Maiti S, Pramanik A, Ghosh S K and Pramanik P 2012 Controlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agent Carbohyd. Polym. 87 2593-604
53. Hua M-Y et al 2011 Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy Biomaterials 32 8999-9010
54. Hua M-Y, Yang H-W, Chuang C-K, Tsai R-Y, Chen W-J, Chuang K-L, Chang Y-H, Chuang H-C and Pang S-T 2010 Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer Biomaterials 31 7355-63
55. Park S, Kim H S, Kim W J and Yoo H S 2012 Pluronic@Fe3O4 nanoparticles with robust incorporation of doxorubicin by thermo-responsiveness Int. J. Pharm. 424 107-14
56. Quan Q et al 2011 HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy Mol. Pharm. 8 1669-76
57. Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X and Chen X 2010 PET/NIRF/MRI triple functional iron oxide nanoparticles Biomaterials 31 3016-22
58. Dufort S, Sancey L and Coll J-L 2012 Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution Adv. Drug Deliv. Rev. 64 179-89
59. Fanali G, di Masi A, Trezza V, Marino M, Fasano M and Ascenzi P 2012 Human serum albumin: from bench to bedside Mol. Aspects Med. 33 209-90
60. Dreis S, Rothweiler F, Michaelis M, Cinatl J Jr, Kreuter J and Langer K 2007 Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles Int. J. Pharm. 341 207-14 (Pubitemid 47088104)
61. Ying X-Y, Du Y-Z, Hong L-H, Yuan H and Hu F-Q 2011 Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: preparation and characteristics J. Magn. Magn. Mater. 323 1088-93
62. Bothun G D, Lelis A, Chen Y, Scully K, Anderson L E and Stoner M A 2011 Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake Nanomedicine: NBM 7 797-805
63. Pradhan P, Banerjee R, Bahadur D, Koch C, Mykhaylyk O and Plank C 2010 Targeted magnetic liposomes loaded with doxorubicin Methods Mol. Biol. 605 279-93
64. Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Döblinger M, Banerjee R, Bahadur D and Plank C 2010 Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Control. Release 142 108-21
65. Cukierman E and Khan D R 2010 The benefits and challenges associated with the use of drug delivery systems in cancer therapy Biochem. Pharmacol. 80 762-70
66. Kawano K, Onose E, Hattori Y and Maitani Y 2009 Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone Mol. Pharm. 6 98-104
67. Kawano K and Maitani Y 2011 Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitro J. Drug. Deliv. 2011 160967
68. Deng L, Ke X, He Z, Yang D, Gong H, Zhang Y, Jing X, Yao J and Chen J 2012 A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer Int. J. Nanomed. 7 5053-65
69. Parveen S, Misra R and Sahoo S K 2012 Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging Nanomedicine 8 147-66
70. Ying X-Y, Cui D, Yu L and Du Y-Z 2011 Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin Carbohyd. Polym. 84 1357-64
71. Prasad P, Cai P, Shuhendler A, Rauth A M and Wu X Y 2012 Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts Cancer Lett. 334 263-73
72. Kuo Y-C and Liang C-T 2011 Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells Colloids Surf. B 85 131-7
73. Kang K W, Chun M-K, Kim O, Subedi R K, Ahn S-G, Yoon J-H and Choi H-K 2010 Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy Nanomedicine: NBM 6 210-3
74. Subedi R K, Kang K W and Choi H-K 2009 Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin Eur. J. Pharm. Sci. 37 508-13
75. Sanson C, Schatz C, Le Meins J-F, Soum A, Thévenot J, Garanger E and Lecommandoux S 2010 A simple method to achieve high doxorubicin loading in biodegradable polymersomes J. Control. Release 147 428-35
76. Sanson C et al 2011 Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy ACS Nano 5 1122-40
77. Yang H-M, Oh B C, Kim J H, Ahn T, Nam H-S, Park C W and Kim J-D 2011 Multifunctional poly(aspartic acid) nanoparticles containing iron oxide nanocrystals and doxorubicin for simultaneous cancer diagnosis and therapy Colloids Surf. A 391 208-15
78. Liao C, Sun Q, Liang B, Shen J and Shuai X 2011 Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide Eur. J. Radiol. 80 699-705
79. Chen H, Li B, Ren X, Li S, Ma Y, Cui S and Gu Y 2012 Multifunctional near-infrared-emitting nano-conjugates based on gold clusters for tumor imaging and therapy Biomaterials 33 8461-76
80. Wu X, He X, Wang K, Xie C, Zhou B and Qing Z 2010 Ultrasmall near-infrared gold nanoclusters for tumor fluorescence imaging in vivo Nanoscale 2 2244-9
81. Safari D et al 2012 Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine Nanomedicine 7 651-62
82. Sapozhnikova V et al 2012 Use of near-infrared luminescent gold nanoclusters for detection of macrophages J. Biomed. Opt. 17 026006
83. Wang Y, Chen J and Irudayaraj J 2011 Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer ACS Nano 5 9718-25
84. Shang L, Dong S and Nienhaus G U 2011 Ultra-small fluorescent metal nanoclusters: synthesis and biological applications Nano Today 6 401-18
85. Zhang X-D, Wu D, Shen X, Liu P-X, Fan F-Y and Fan S-J 2012 In vivo renal clearance, biodistribution, toxicity of gold nanoclusters Biomaterials 33 4628-38
86. Chen H, Li S, Li B, Ren X, Li S, Mahounga D M, Cui S, Gu Y and Achilefu S 2012 Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy Nanoscale 4 6050-64
87. Nam J, Won N, Bang J, Jin H, Park J, Jung S, Jung S, Park Y and Kim S 2013 Surface engineering of inorganic nanoparticles for imaging and therapy Adv. Drug Deliv. Rev. 65 622-48
88. Kim C K, Ghosh P, Pagliuca C, Zhu Z-J, Menichetti S and Rotello V M 2009 Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells J. Am. Chem. Soc. 131 1360-1
89. Park J, Nam J, Won N, Jin H, Jung S, Jung S, Cho S-H and Kim S 2011 Compact and stable quantum dots with positive, negative, or zwitterionic surface: specific cell interactions and non-specific adsorptions by the surface charges Adv. Funct. Mater. 21 1558-66
90. Muro E, Pons T, Lequeux N, Fragola A, Sanson N, Lenkei Z and Dubertret B 2010 Small and stable sulfobetaine zwitterionic quantum dots for functional live-cell imaging J. Am. Chem. Soc. 132 4556-7
91. Susumu K et al 2011 Multifunctional compact zwitterionic ligands for preparing robust biocompatible semiconductor quantum dots and gold nanoparticles J. Am. Chem. Soc. 133 9480-96
92. Damiano M G, Mutharasan R K, Tripathy S, McMahon K M and Thaxton C S 2013 Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery Adv. Drug Deliv. Rev. 65 649-62
93. Cormode D P et al 2008 Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform Nano Lett. 8 3715-23
94. Skajaa T, Cormode D P, Jarzyna P A, Delshad A, Blachford C, Barazza A, Fisher E A, Gordon R E, Fayad Z A and Mulder W J M 2011 The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis Biomaterials 32 206-13
95. Taratula O, Garbuzenko O, Savla R, Wang Y A, He H and Minko T 2011 Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes Curr. Drug Deliv. 8 59-69
96. Dietrich S, Chandra S, Georgi C, Thomas S, Makarov D, Schulze S, Hietschold M, Albrecht M, Bahadur D and Lang H 2012 Design, characterization and magnetic properties of Fe3O4-nanoparticle arrays coated with PEGylated-dendrimers Mater. Chem. Phys. 132 292-9
97. Lamanna G et al 2011 Dendronized iron oxide nanoparticles for multimodal imaging Biomaterials 32 8562-73
98. Dietrich S, Schulze S, Hietschold M and Lang H 2011 Au nanoparticles stabilised by PEGylated low generation PAMAM dendrimers: design, characterisation and properties J. Colloid Interface Sci. 359 454-60
99. Agalave S G, Maujan S R and Pore V S 2011 Click chemistry: 1,2,3-triazoles as pharmacophores Chem. Asian J. 6 2696-718
100. Yao Y, Sun Z, Zou Z and Li H 2011 Quinolino-triazole linked gold nanoparticles as sensitive 'turn-on' fluorescent Cd2+ probes Nanotechnology 22 435502
101. Hua C, Zhang W H, De Almeida S R M, Ciampi S, Gloria D, Liu G, Harper J B and Gooding J J 2012 A novel route to copper(II) detection using 'click' chemistry-induced aggregation of gold nanoparticles Analyst 137 82-6
102. Locatelli E, Ori G, Fournelle M, Lemor R, Montorsi M and Comes Franchini M 2011 Click chemistry for the assembly of gold nanorods and silver nanoparticles Chemistry 17 9052-6
103. Voliani V, Ricci F, Signore G, Nifosì R, Luin S and Beltram F 2011 Multiphoton molecular photorelease in click-chemistry-functionalized gold nanoparticles Small 7 3271-5
104. He X, Wu X, Cai X, Lin S, Xie M, Zhu X and Yan D 2012 Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties Langmuir 28 11929-38